Estia Health Ltd (ASX: EHE) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Estia Health Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Estia Health Ltd (ASX: EHE)
Latest News
Share Gainers
Why Estia Health, GQG, GUD, and Pilbara Minerals shares are storming higher
Mergers & Acquisitions
Why is this ASX 300 healthcare share charging 9% higher today?
Share Market News
Returning capital: These ASX companies have been buying back their shares in 2023
Share Gainers
Why Estia Health, Graincorp, Novonix, and Polynovo shares are racing higher
Share Gainers
3 ASX All Ords shares rocketing over 10% on big news
Opinions
Why this fund manager thinks these 2 outperforming ASX shares can keep beating the market
Investing Strategies
‘Attractive valuations’: 2 ASX shares to buy now before they explode
Share Gainers
Why Core Lithium, Estia Health, Kingsgate, and St Barbara shares are charging higher
Mergers & Acquisitions
Estia Health share price jumps 21% on takeover approach
Cheap Shares
I think value investors would love to buy these 2 cheap ASX shares
Opinions
Waiting for ASX shares to bottom? Why you could miss out on a stock market rally
Opinions
This ‘very attractive’ ASX share could be a takeover target with over 50% upside
Frequently Asked Questions
-
Yes, Estia Health has historically paid two fully franked shareholder dividends a year.
-
Estia Health generally pays its shareholder dividends in March and September.
-
Yes, Estia Health has a dividend reinvestment plan (DRP) which allows eligible shareholders to invest all or part of their dividend payments into additional fully paid shares. The extent to which the DRP applies to future dividends is included as part of each dividend announcement.
-
Estia Health Ltd listed on the ASX on 5 December 2014.
Dividend Payment History Data provided by Morningstar.
Ex-Date | Amount | Franking | Type | Payable |
---|---|---|---|---|
24 Feb 2023 | $0.0370 | 100.00% | Interim | 17 Mar 2023 |
25 Feb 2022 | $0.0235 | 100.00% | Interim | 18 Mar 2022 |
27 Aug 2021 | $0.0230 | 100.00% | Final | 17 Sep 2021 |
28 Feb 2020 | $0.0540 | 100.00% | Interim | 27 Mar 2020 |
04 Sep 2019 | $0.0780 | 100.00% | Final | 02 Oct 2019 |
05 Mar 2019 | $0.0800 | 100.00% | Interim | 27 Mar 2019 |
06 Sep 2018 | $0.0800 | 100.00% | Final | 28 Sep 2018 |
01 Mar 2018 | $0.0780 | 100.00% | Interim | 23 Mar 2018 |
07 Sep 2017 | $0.0000 | 100.00% | Final | 29 Sep 2017 |
30 Sep 2016 | $0.1280 | 100.00% | Final | 07 Nov 2016 |
22 Mar 2016 | $0.1280 | 100.00% | Interim | 20 Apr 2016 |
EHE ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Estia Health Ltd
Estia Health Ltd (ASX: EHE) operates residential aged care facilities in Australia. The company has more than 70 facilities in Victoria, South Australia, New South Wales, and Queensland. Estia’s facilities provide accommodation, clinical care, and daily living services for around 8,000 residents. The company’s clinical care services include 24-hour nursing care, personal care, wound management, administering pharmaceuticals, physiotherapy, and occupational therapy. Federal government funding makes up the majority of Estia’s total revenue.
EHE Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
10 Aug 2023 | $3.12 | $0.01 | 0.32% | 9,251,610 | $3.11 | $3.13 | $3.11 |
09 Aug 2023 | $3.11 | $0.01 | 0.32% | 13,577,335 | $3.09 | $3.11 | $3.09 |
08 Aug 2023 | $3.10 | $0.02 | 0.65% | 39,000,100 | $3.10 | $3.10 | $3.09 |
07 Aug 2023 | $3.08 | $0.24 | 8.45% | 27,511,341 | $3.10 | $3.12 | $3.08 |
04 Aug 2023 | $2.84 | $-0.02 | -0.70% | 322,838 | $2.85 | $2.85 | $2.83 |
03 Aug 2023 | $2.86 | $-0.01 | -0.35% | 223,736 | $2.85 | $2.87 | $2.80 |
02 Aug 2023 | $2.87 | $0.05 | 1.77% | 290,124 | $2.82 | $2.90 | $2.80 |
01 Aug 2023 | $2.82 | $0.03 | 1.08% | 744,966 | $2.78 | $2.85 | $2.77 |
31 Jul 2023 | $2.79 | $0.00 | 0.00% | 1,054,372 | $2.80 | $2.81 | $2.78 |
28 Jul 2023 | $2.79 | $0.03 | 1.09% | 523,824 | $2.75 | $2.79 | $2.69 |
27 Jul 2023 | $2.76 | $-0.03 | -1.08% | 225,333 | $2.81 | $2.81 | $2.74 |
26 Jul 2023 | $2.79 | $-0.02 | -0.71% | 174,949 | $2.81 | $2.81 | $2.78 |
25 Jul 2023 | $2.81 | $0.02 | 0.72% | 319,089 | $2.79 | $2.85 | $2.76 |
24 Jul 2023 | $2.79 | $-0.12 | -4.12% | 432,103 | $2.92 | $2.92 | $2.78 |
21 Jul 2023 | $2.91 | $0.04 | 1.39% | 703,276 | $2.87 | $2.91 | $2.85 |
20 Jul 2023 | $2.87 | $-0.04 | -1.37% | 262,459 | $2.91 | $2.92 | $2.87 |
19 Jul 2023 | $2.91 | $0.00 | 0.00% | 467,120 | $2.93 | $2.93 | $2.87 |
18 Jul 2023 | $2.91 | $0.00 | 0.00% | 930,765 | $2.94 | $2.94 | $2.89 |
17 Jul 2023 | $2.91 | $-0.01 | -0.34% | 195,449 | $2.91 | $2.94 | $2.88 |
14 Jul 2023 | $2.92 | $0.01 | 0.34% | 187,910 | $2.89 | $2.93 | $2.85 |
13 Jul 2023 | $2.91 | $0.05 | 1.75% | 501,759 | $2.89 | $2.94 | $2.87 |
12 Jul 2023 | $2.86 | $-0.05 | -1.72% | 1,032,123 | $2.92 | $2.93 | $2.85 |
11 Jul 2023 | $2.91 | $-0.01 | -0.34% | 162,956 | $2.91 | $2.93 | $2.89 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
02 Mar 2023 | Karen Penrose | Buy | 7 | $14,982 |
On-market trade.
|
24 Feb 2023 | Gary Weiss | Buy | 25 | $51,750 |
On-market trade.
|
21 Nov 2022 | Sean Bilton | Issued | 367 | $778,521 |
Issue of securities. 9,33,855 Performance Rights
|
17 Nov 2022 | Sean Bilton | Buy | 48 | $105,998 |
On-market trade.
|
15 Nov 2022 | Sean Bilton | Buy | 105 | $224,283 |
Conversion of securities.
|
15 Nov 2022 | Sean Bilton | Exercise | 105 | $224,283 |
Conversion of securities. 5,48,887 Performance Rights
|
15 Nov 2022 | Sean Bilton | Issued | 17 | $37,610 |
Issue of securities. 5,66,628 Performance Rights
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Dr Gary Hilton Weiss | Non-Executive DirectorNon-Executive Chairman | Feb 2016 |
Dr Weiss has international business experience and has been involved in numerous cross-border mergers and acquisitions. Gary is Chairman of Cromwell Property Group Limited and Ardent Leisure Group Limited, Executive Director of Ariadne Australia Limited, and a Director of Thorney Opportunities Limited and Hearts and Minds Investments Limited. Gary is also a Commissioner of the Australian Rugby League Commission and a Director of the Victor Chang Cardiac Research Institute. Gary was Chairman of Coats Group plc from May 2004 to April 2012, Chairman of Clearview Wealth Ltd from 2013 to May 2016, Chairman of Ridley Corporation from June 2015 to June 2020, Executive Director of Guinness Peat Group plc from 1990 to April 2011 and has held directorships of numerous companies, including The Straits Trading Co Limited, Tag Pacific Limited, Pro-Pac Packaging Limited, Premier Investments Ltd, Westfield Group, Tower Australia Limited, Australian Wealth Management Limited, Tyndall Australia Limited (Deputy Chairman), Joe White Maltings Limited (Chairman), CIC Limited, Whitlam Turnbull & Co Limited and Industrial Equity Limited. Gary has authored numerous articles on a variety of legal and commercial topics. Gary was awarded a Member of the Order of Australia (AM) in recognition of his services to business and to the community. Dr Weiss is member of Property and Investment Committee, COVID-19 Committee, Royal Commission and chair of Regulatory Committee. Other directorships includes Ariadne Australia Limited, Ardent Leisure Group Limited (Chair), Thorney Opportunities Ltd, Hearts and Minds Investments Limited, Cromwell Property Group (Chair), Straits Trading Co. Ltd (resigned 30 September 2020), Ridley Corporation Limited (resigned 26 August Ridley Corporation Limited (resigned 26 August 2020), Premier Investments Limited (28 July 2018).
|
Ms Helen Kurincic | Non-Executive Director | Jul 2017 |
Ms Kurincic has executive and Non-executive experience across the healthcare sector. Helen is Chairman of Integral Diagnostics Limited and McMillan Shakespeare Limited, and a Non-executive Director of HBF Health Limited and Victorian Clinical Genetics Service. Helen was previously the Chief Operating Officer and Director of Genesis Care for seven years from early inception in 2007, creating Australia's largest radiation oncology and cardiology service business. Previous roles also include Non-executive Director of Sirtex Medical Limited, Non-executive Director of DCA Group Limited which included residential aged care in Australia and New Zealand, Non-executive Director of AMP Capital Investor's aged care business Domain Principal Group, CEO and Executive Director of residential aged care provider Benetas and Board member of Melbourne Health and Orygen Research Centre. Helen has also been actively involved in government policy reform across various areas of the healthcare sector. She is chair of Risk Management Committee and COVID-19 Committee.
|
Ms Karen Lee Collett Penrose | Non-Executive Director | Oct 2018 |
Ms Penrose is an experienced Company Director who has served as a full-time Non-executive Director since 2014 on the boards of ASX listed companies across the financial services, aged care, healthcare, resources and infrastructure sectors. Karen's executive career was in leadership and CFO roles, mainly in financial services. Karen worked with CBA and HSBC for over 20 years. She is passionate about consumer outcomes and financial management and is well-versed in operating in a rapidly changing regulatory environment. Karen is a Director and Chair of the Audit Committee of Bank of Queensland, Ramsay Health Care and Vicinity Centres. She is also Director of Marshall Investments Pty Ltd and Rugby Australia Limited. Karen was formally a director of Future Generation Global Investment Company Limited, AWE Limited and Spark Infrastructure Group Limited. Karen is a member of Chief Executive Women. She is member of Risk Management Committee, Royal Commission & Regulatory Committee, COVID-19 Committee. Other Directorships includes: Bank of Queensland Limited, Vicinity Centres, Ramsay Health Care, Spark Infrastructure Group (resigned May 2020), Future Generation Investment Company Limited (resigned October 2018).
|
Ms Norah Kathleen Barlow | Non-Executive Director | Nov 2014 |
Ms Barlow is amongst Australasia's most experienced and respected executives and directors, with an in-depth knowledge of the aged and healthcare sector. Norah also holds experience as the highly-respected former CEO and former Director of Summerset Group, an NZX and ASX-listed company named Australasia's best retirement village operator four years running. Norah has a background across business leadership and management, strategy, corporate finance, governance, tax and accounting. Norah was President of the Retirement Villages Association (NZ) for seven years and made an Officer of the New Zealand Order of Merit for services to business in 2014. Norah was also a Non-executive Director of Ingenia Communities Group, Evolve Education Group Limited, and chair of the Audit Committee for Methven Limited. Norah stepped down as CEO of Estia Health in November 2018 and remains on the board as a Non-executive Director. Norah is currently Chief Executive of Heritage Lifecare Limited. She is member of Property and Investment Committee. She is former director of Evolve Education Group Limited.
|
Mr Paul Foster | Non-Executive Director | Feb 2016 |
Mr Foster is an experienced Financial Services professional and Company Director, with more than 20 years of investment experience in the infrastructure, private equity and real estate asset classes, including substantial investments in the healthcare sector. Paul is a Managing Director at Pacific Equity Partners, one of Australia's largest alternative investment management firms. He is also a Non-executive Director of WINconnect Pty Ltd, PEP Services Pty Ltd and PEP Advisory Services Pty Ltd. Paul was a Director of the Opal Aged Care Group (formerly Domain Principal Group) between 2010 and 2015 and was Chairman of the Group in 2011. Paul was head of AMP Capital's Infrastructure investment business in Australia and New Zealand until 2015. Before AMP Capital, he was an investment professional at Macquarie Group and Perpetual Investments. He is member of Risk Management Committee and Property and Investment Committee.
|
Mr Sean Bilton | Chief Operating OfficerChief Executive OfficerManaging Director | Jul 2022 |
--
|
Professor Simon Willcock | Non-Executive Director | Sep 2022 |
Professor Willcock has been the independent Chair of Estia Health's Clinical Governance Committee since 2019, has had an academic and clinical career including a number of Commonwealth and State Ministerial appointments. He is a Director of Sydney North Primary Health Network and was previously a Director and Chair of Avant Mutual Group. Professor Willcock is currently Program Director for Primary Care and Wellbeing Services at MQ Health, a subsidiary of Macquarie University.
|
Ms Leanne Ralph | Company Secretary | Apr 2019 |
-
|
Leanne Ralph | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Citicorp Nominees Pty Limited | 49,805,003 | 19.32% |
HSBC Custody Nominees (Australia) Limited | 35,108,126 | 13.62% |
J P Morgan Nominees Australia Pty Limited | 34,214,878 | 13.27% |
National Nominees Limited | 22,371,352 | 8.68% |
Network Investment Holdings Pty Ltd | 17,245,858 | 6.69% |
Argo Investments Limited | 14,309,250 | 5.55% |
BNP Paribas Noms Pty Ltd <Drp> | 11,307,867 | 4.39% |
Network Investment Holdings Pty Ltd i | 10,000,000 | 3.88% |
3Rd Wave Investors Pty Ltd | 4,250,000 | 1.65% |
Emalyn Holdings Pty Limited <John Kennedy A/C> | 4,102,766 | 1.59% |
Hsbc Custody Nominees (Australia) Limited i | 4,001,613 | 1.55% |
Mr Mark Edward Kennedy <Mark Edward Kennedy A/C> | 1,910,678 | 0.74% |
Mrs Julia Michelle Manken | 1,525,000 | 0.59% |
Skip Enterprises Pty Ltd <Farquhar A/C> | 1,442,768 | 0.56% |
Mark Edward Kennedy | 1,277,438 | 0.50% |
Kennbros Pty Limited | 1,156,834 | 0.45% |
Alphagen Capital Pty Ltd | 1,000,000 | 0.39% |
Custodial Services Limited <Beneficiaries Holding A/C> | 822,329 | 0.32% |
Netwealth Investments Limited <Super Services A/C> | 704,823 | 0.27% |
Citicorp Nominees Pty Limited i | 560,192 | 0.22% |